Sudden hyposmia as a prevalent symptom of COVID-19 infection.
Marchese-Ragona, R.; Ottaviano, G.; Nicolai, P.; Vianello, A.; Carecchio, M.
Show abstract
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has recently caused a pandemic that has involved Italy as the second worldwide nation in terms of infected patients and deaths. The clinical manifestation of Covid-19 ranges from asymptomatic carrier status to severe pneumonia. Asymptomatic individuals in Covid-19 are those who are carriers of the virus but do not show clinical symptoms and are able to transmit the disease in the same degree as symptomatic carriers. In order to contain contagions is of supreme importance to identify asymptomatic patients because this subpopulation is one of the main factors contributing to the spread of this disease. We report on six Italian patients with COVID-19 who presented sudden hyposmia as the only or most prominent disease manifestation, without upper or lower respiratory tract involvement or other major features of the disease. A supra-threshold olfaction test confirmed the hyposmia in all patients. The onset of hyposmia during a Covid-19 outbreak should be considered as a warning sign of an infection that requires a diagnostic test for Covid-19
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- The COVID-19 infection in Italy: a statistical study of an abnormally severe disease 94%
- Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data 91%
- Early Outpatient Treatment Of COVID-19: A Retrospective Analysis Of 392 Cases In Italy 90%
Similar papers in this journal
- Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study 92%
- Clinical characteristics of Coronavirus Disease 2019 (COVID-19) patients in Kuwait 92%
- First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain 92%
Similar papers in this journal
- A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms 92%
- The antibody response to SARS-CoV-2 increases over 5 months in patients with anosmia/dysgeusia 91%
- Booster dose of BNT162b2 in a CoronaVac primary vaccination protocol improves neutralization of SARS-CoV-2 Omicron variant 86%
Similar papers in this journal
- Spread of the SARS-CoV-2 UK-variant in the South East of France: impact on COVID-19 patients’ age, comorbidity profiles and clinical presentation 92%
- SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy 91%
- Results of an early second PCR test performed on SARS-CoV-2 positive patients may indicate risk for severe COVID-19 91%
Similar papers in this journal
- Going beyond clinical routine in SARS-CoV-2 antibody testing - A multiplex corona virus antibody test for the evaluation of cross-reactivity to endemic coronavirus antigens 90%
- Early Prediction of Disease Progression in 2019 Novel Coronavirus Pneumonia Patients Outside Wuhan with CT and Clinical Characteristics 89%
- Distinct systems serology features in children, elderly and COVID patients 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.